1. + Screening for Genetic Disease Douglas Riegert-Johnson, MD Assistant Professor of Medicine and Medical Genetics Mayo Clinic Florida Amelia Island Mayo Clinic Review Course…

Slide 1 What’s New in HER2: Current Issues in HER2 Positive Breast Cancer Kristine Abueg, RN, MSN, OCN®, CBCN ® Oncology Clinical Trials Kaiser Permanente, Roseville…

Slide 1 Track 3 NanoMedicine Session 2 11 Slide 2 EJ Auzenne 1, RD Weiss 2, J Klostergaard 1 The University of Texas, MD Anderson Cancer Center, Houston, TX 1 Arkival Technology…

Clinical Application of HER2-Directed Therapies in Breast Cancer HERA Results: Adjuvant Trastuzumab (8-Year Follow-up): OS â 2 y vs 1 y ALTTO Trial: Schema MARIANNE: Phase…

Whatâs new in HER2: Part II Whatâs New in HER2: Current Issues in HER2 Positive Breast Cancer Kristine Abueg, RN, MSN, OCN®, CBCN ® Oncology Clinical Trials Kaiser…

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population  Hasan Korkaya, Gwang-il Kim,…